Letizia Terenzi

Dr. Letizia Terenzi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
DEDario Esposito
Dario Esposito
KBKaterina Bernardi
Katerina Bernardi
ABArianna Belli
Arianna Belli
VGValentina Gasparri
Valentina Gasparri
SRSara Romano
Sara Romano
MFMauro Ferrara
Mauro Ferrara
Neurodevelopmental disorders, such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), do often present in comorbidity among them and with other medical conditions, including sleep and gastrointestinal (GI) disorders and somatic complaints. An anonymous online survey based on standardized questionnaires (SDSC, KL-ASD, APSI, ROME V CRITERIA, CPRS, CBCL) was completed by the parents of 46 preschoolers diagnosed with ASD. A high prevalence (47%) of ADHD symptoms in this population was found, surpassing previous estimates. Sleep disturbances, especially difficulties in initiating and maintaining sleep and sleep–wake transition, are more pronounced in ASD patients with comorbid ADHD. Additionally, in patients over 4 years old, there is a high prevalence of functional GI symptoms (Rome V criteria: 38%). Parental stress is significantly associated with ADHD symptoms, sleep disorders, and GI symptoms. Comprehensive assessments considering both core symptoms of neurodevelopmental disorders and associated comorbidities are crucial for more effective treatment strategies and improved wellbeing in affected individuals and their families.

21 March 2024 in Children
Verified
Journal Article
Open access
PDF file
VMValeria Mammarella
Valeria Mammarella
EMElena Monducci
Elena Monducci
AMAlessia Maffucci
Alessia Maffucci
LTLetizia Terenzi
Letizia Terenzi
MFMauro Ferrara
Mauro Ferrara
Carla SogosCarla Sogos
Carla Sogos
1. Background: Autism spectrum disorder and psychotic risk show several overlapping symptoms, so differential diagnosis is often difficult. In addition, there is a high rate of comorbidity between the two conditions, which further complicates the work of clinicians. We evaluated the presence of subthreshold psychotic symptoms and/or defined psychotic risk syndromes in autistic children and adolescents; we compared the prevalence, type, and severity of psychotic risk symptoms with those of a group of non-autistic patients at clinical high risk for psychosis (CHR-P). 2. Methods: In total, 23 autistic patients and 14 CHR-P patients without autism (aged 8–17) were enrolled in the study. The main assessment was made through clinical interviews for autism (Autism Diagnostic Observation Schedule, Second Edition—ADOS-2, Autism Diagnostic Interview, Revised—ADI-R) and psychotic risk (Schizophrenia Proneness Instrument, Child and Youth version—SPI-CY, Structured Interview for Psychosis Risk Syndromes—SIPS). 3. Results: No above-threshold psychotic risk symptoms were detected in our autistic patients, but subthreshold psychotic symptoms were identified in all areas. Specific items from all four dimensions of SIPS appear to be more specific for psychotic risk than autism without comorbidity. 4. Conclusions: An a priori screening of psychotic risk in neurodiverse populations is fundamental to prevent more severe conditions. Research should clarify the effective specificity of the available tools to modify them to improve their detection capability.

26 December 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
VBValentina Baglioni
Valentina Baglioni
LTLetizia Terenzi
Letizia Terenzi
CCC. Corazzina
C. Corazzina
DEDario Esposito
Dario Esposito
INIlaria Notaristefano
Ilaria Notaristefano
FPFrancesco Pisani
Francesco Pisani